PharmaShots | Incisive News in 3 Shots

Subscribe Now

Malaria

BioNTech Plans to Initiate the Clinical Study of Malaria and Tuberculosis Vaccines in 2022

BioNTech Plans to Initiate the Clinical Study of Malaria and Tuberculosis Vaccines in 2022

July 27, 2021

Amivas's Artesunate Receives the US FDA's Approval for Treatment of Severe Malaria

Amivas's Artesunate Receives the US FDA's Approval for Treatment of Severe Malaria

May 27, 2020

Novavax and Serum Institute of India Collaborate to Develop and Commercialize Vaccines for Malaria

Novavax and Serum Institute of India Collaborate to Develop and Commercialize Vaccines for Malaria

March 12, 2020

60 Degree Pharma Receives U.S. FDA Approval for ARAKODA (tafenoquine) tablets for Treating Malaria

60 Degree Pharma Receives U.S. FDA Approval for ARAKODA (tafenoquine) tablets for Treating Malaria

August 9, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us